JAK inhibitor BMS-986165, Purity ≥98%

Synonym: Deucravacitinib; BMS-986165; 1609392-27-9; Tyk2-IN-4; Sotyktu; BMS986165; N0A21N6RAU; JAK inhibitor

MDL: MFCD31715455
CAS Number: 1609392-27-9
Compound CID: 134821691

Product Size

2 mg; 5 mg; 10 mg; 25 mg; 50 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

BMS-986165, soluble in DMSO and insoluble in ethanol and water, is an available JAK small molecule inhibitor with potential antineoplastic activity. It targets IL-12, IL-13, JAK1 JH2, and Tyk2 JH2.

Molecular Weight

425.46

Molecular Formula

C₂₀H₁₉D₃N₈O₃

Targets

IL-12; IL-13; JAK1 JH2: 1 nM; Tyk2 JH2: 0.2 nM

Form

Lyophilized powder

Purity

≥98%

Solubility

DMSO: 27 mg/mL (63.46 mM); Water: Insoluble; Ethanol: Insoluble

Identity

Confirmed by NMR/HPLC/MS.

Stability

The product is stable for three years when stored at the recommended temperature in lyophilized powder.

Applications

BMS-986165 is employed in research to study TYK2 inhibition and its potential in treating autoimmune diseases.

Storage

Store at -20ºC.